Theravance Bio Ord (TBPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -182,219 | -237,038 | -156,284 | -9,575 | -109,335 |
| Depreciation Amortization | 2,989 | 3,274 | 2,653 | 3,251 | 3,844 |
| Accounts receivable | -1,633 | -90 | -199 | N/A | N/A |
| Accounts payable and accrued liabilities | 8,717 | 3,917 | 2,113 | -1,532 | 3,312 |
| Other Working Capital | -37,783 | 12,770 | 10,176 | -134,302 | 584 |
| Other Operating Activity | 41,072 | 42,012 | 20,582 | 23,051 | 18,167 |
| Operating Cash Flow | $-168,857 | $-175,155 | $-120,959 | $-119,107 | $-83,428 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 1,018 | 100 | 100 | 715 |
| PPE Investments | -2,647 | -3,107 | -2,734 | -2,590 | -3,627 |
| Purchase Of Investment | -73,011 | -168,893 | N/A | N/A | N/A |
| Sale Of Investment | 186,697 | 65,564 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -833 | 0 | 60 | -140 |
| Investing Cash Flow | $111,039 | $-106,251 | $-2,634 | $-2,430 | $-3,052 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -69 | -206 |
| Common Stock Issued | 82,141 | N/A | N/A | N/A | N/A |
| Common Stock Repurchased | -756 | -178 | N/A | N/A | N/A |
| Other Financing Activity | -75 | 370,799 | 123,593 | 121,606 | 86,686 |
| Financing Cash Flow | $81,310 | $370,621 | $123,593 | $121,537 | $86,480 |
| Beginning Cash Position | 89,215 | N/A | N/A | N/A | N/A |
| End Cash Position | 112,707 | 89,215 | N/A | N/A | N/A |
| Net Cash Flow | $23,492 | $89,215 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -168,857 | -175,155 | -120,959 | -119,107 | -83,428 |
| Capital Expenditure | -2,647 | -3,107 | -2,734 | -2,590 | -3,627 |
| Free Cash Flow | -171,504 | -178,262 | -123,693 | -121,697 | -87,055 |